Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NewLink Genetics Announces Exclusive Worldwide License Agreement with Ellipses Pharma for Development of and Rights to Commercialization of NLG207

firstwordpharmaDecember 24, 2019

Tag: NewLink Genetics , license agreement , Ellipses Pharma

PharmaSources Customer Service